A. Brisuda
Impact in
- Urology top 5%
- Urological Disorders and Treatments
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in ⓘ
- Co-authors
- Marek Babjuk (12 shared papers)Évanguelos Xylinas (2 shared papers)Michael Rink (2 shared papers)Yair Lotan (2 shared papers)Shahrokh F. Shariat (2 shared papers)Douglas S. Scherr (2 shared papers)Yves Fradet (2 shared papers)Marc Zerbib (2 shared papers)
- Journals
- Cytopathology (2 papers)Cancer Medicine (2 papers)PLoS ONE (1 paper)Advances in experimental medicine and biology (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- CzechiaUnited StatesFrance
In The Last Decade
A. Brisuda
16 papers receiving 388 citations
Peers
Comparison fields: 5 of 45
- Urology 72
- Cancer Research 95
- Surgery 229
- Pulmonary and Respiratory Medicine 116
- Molecular Biology 150
Countries citing papers authored by A. Brisuda
This map shows the geographic impact of A. Brisuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Brisuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Brisuda more than expected).
Fields of papers citing papers by A. Brisuda
This network shows the impact of papers produced by A. Brisuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Brisuda. The network helps show where A. Brisuda may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Brisuda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 130 | |
| 2 | 2013 | 104 | |
| 3 | 2016 | 48 | |
| 4 | 2015 | 38 | |
| 5 | 2013 | 19 | |
| 6 | 2018 | 9 | |
| 7 | 2016 | 7 | |
| 8 | 2020 | 7 | |
| 9 | 2019 | 7 | |
| 10 | 2015 | 5 | |
| 11 | 2020 | 5 | |
| 12 | 2014 | 5 | |
| 13 | Positron emission tomography and clinical predictors of survival in primary extragonadal germ cell tumors. | 2012 | 4 |
| 14 | 2024 | 2 | |
| 15 | 2020 | 2 | |
| 16 | 2024 | 1 | |
| 17 | 2013 | 0 | |
| 18 | 2024 | 0 | |
| 19 | 2023 | 0 | |
| 20 | 2017 | 0 |
About A. Brisuda
A. Brisuda is a scholar working on Urology, Surgery, Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 20 papers that have together received 393 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (15 papers), Urinary and Genital Oncology Studies (8 papers), Urological Disorders and Treatments (6 papers), MicroRNA in disease regulation (2 papers), Cancer, Lipids, and Metabolism (2 papers), Epigenetics and DNA Methylation (2 papers), Cancer-related molecular mechanisms research (2 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Urology (72 citations), Cancer Research (95 citations), Surgery (229 citations), Pulmonary and Respiratory Medicine (116 citations) and Molecular Biology (150 citations). A. Brisuda has collaborated with scholars based in Czechia, United States and France. Frequent co-authors include Marek Babjuk, Évanguelos Xylinas, Michael Rink, Yair Lotan, Shahrokh F. Shariat, Douglas S. Scherr, Yves Fradet, Marc Zerbib, Pierre I. Karakiewicz and Brian D. Robinson. Their work appears in journals such as Cytopathology, Cancer Medicine, PLoS ONE, Advances in experimental medicine and biology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.